BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 16963157)

  • 1. Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studies.
    Vergura R; Valenti E; Hebbes CP; Gavioli EC; Spagnolo B; McDonald J; Lambert DG; Balboni G; Salvadori S; Regoli D; Calo' G
    Peptides; 2006 Dec; 27(12):3322-30. PubMed ID: 16963157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist.
    Vergura R; Balboni G; Spagnolo B; Gavioli E; Lambert DG; McDonald J; Trapella C; Lazarus LH; Regoli D; Guerrini R; Salvadori S; Caló G
    Peptides; 2008 Jan; 29(1):93-103. PubMed ID: 18069089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505).
    Dietis N; McDonald J; Molinari S; Calo G; Guerrini R; Rowbotham DJ; Lambert DG
    Br J Anaesth; 2012 Feb; 108(2):262-70. PubMed ID: 22194444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance.
    Aguila B; Coulbault L; Boulouard M; Léveillé F; Davis A; Tóth G; Borsodi A; Balboni G; Salvadori S; Jauzac P; Allouche S
    Br J Pharmacol; 2007 Dec; 152(8):1312-24. PubMed ID: 17982482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.
    Balboni G; Salvadori S; Guerrini R; Negri L; Giannini E; Bryant SD; Jinsmaa Y; Lazarus LH
    J Med Chem; 2004 Jul; 47(16):4066-71. PubMed ID: 15267245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic.
    Balboni G; Fiorini S; Baldisserotto A; Trapella C; Sasaki Y; Ambo A; Marczak ED; Lazarus LH; Salvadori S
    J Med Chem; 2008 Aug; 51(16):5109-17. PubMed ID: 18680274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel delta opioid receptor agonist UFP-512 dually modulates motor activity in hemiparkinsonian rats via control of the nigro-thalamic pathway.
    Mabrouk OS; Marti M; Salvadori S; Morari M
    Neuroscience; 2009 Dec; 164(2):360-9. PubMed ID: 19729051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands.
    Bird MF; Vardanyan RS; Hruby VJ; Calò G; Guerrini R; Salvadori S; Trapella C; McDonald J; Rowbotham DJ; Lambert DG
    Br J Anaesth; 2015 Apr; 114(4):646-56. PubMed ID: 25680364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From the potent and selective mu opioid receptor agonist H-Dmt-d-Arg-Phe-Lys-NH(2) to the potent delta antagonist H-Dmt-Tic-Phe-Lys(Z)-OH.
    Balboni G; Cocco MT; Salvadori S; Romagnoli R; Sasaki Y; Okada Y; Bryant SD; Jinsmaa Y; Lazarus LH
    J Med Chem; 2005 Aug; 48(17):5608-11. PubMed ID: 16107162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological characterization of a novel, highly potent, peptidomimetic delta-opioid radioantagonist, [3H]Tyr-Tic-(2S,3R)-beta-MePhe-Phe-OH.
    Birkas E; Kertesz I; Toth G; Bakota L; Gulya K; Szucs M
    Neuropeptides; 2008 Feb; 42(1):57-67. PubMed ID: 18068762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore.
    Balboni G; Salvadori S; Guerrini R; Negri L; Giannini E; Jinsmaa Y; Bryant SD; Lazarus LH
    J Med Chem; 2002 Dec; 45(25):5556-63. PubMed ID: 12459023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of the potent delta-opioid agonist H-Dmt-Tic-NH-CH(2)-bid into delta-opioid antagonists by N(1)-benzimidazole alkylation(1).
    Balboni G; Guerrini R; Salvadori S; Negri L; Giannini E; Bryant SD; Jinsmaa Y; Lazarus LH
    J Med Chem; 2005 Dec; 48(26):8112-4. PubMed ID: 16366592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
    Tóth G; Ioja E; Tömböly C; Ballet S; Tourwé D; Péter A; Martinek T; Chung NN; Schiller PW; Benyhe S; Borsodi A
    J Med Chem; 2007 Jan; 50(2):328-33. PubMed ID: 17228874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of benzimidazole (Bid) in the delta-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH(2)-Bid (UFP-502).
    Salvadori S; Fiorini S; Trapella C; Porreca F; Davis P; Sasaki Y; Ambo A; Marczak ED; Lazarus LH; Balboni G
    Bioorg Med Chem; 2008 Mar; 16(6):3032-8. PubMed ID: 18178091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly selective fluorescent analogue of the potent delta-opioid receptor antagonist Dmt-Tic.
    Balboni G; Salvadori S; Dal Piaz A; Bortolotti F; Argazzi R; Negri L; Lattanzi R; Bryant SD; Jinsmaa Y; Lazarus LH
    J Med Chem; 2004 Dec; 47(26):6541-6. PubMed ID: 15588089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational analysis of potent and very selective delta opioid dipeptide antagonists.
    Amodeo P; Balboni G; Crescenzi O; Guerrini R; Picone D; Salvadori S; Tancredi T; Temussi PA
    FEBS Lett; 1995 Dec; 377(3):363-7. PubMed ID: 8549756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
    Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological evidence for the involvement of the opioid system in the antidepressant-like effect of adenosine in the mouse forced swimming test.
    Kaster MP; Budni J; Santos AR; Rodrigues AL
    Eur J Pharmacol; 2007 Dec; 576(1-3):91-8. PubMed ID: 17868670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.